Effect of Electronic Cigarettes on Smoking Reduction and Cessation in Korean Male Smokers: A Randomized Controlled Study
Overview
Affiliations
Introduction: New approaches to electronic cigarettes (e-cigarettes) as a form of nicotine replacement therapy (NRT) may reduce the rates of tobacco-related disease and mortality. Therefore, we investigated the effect of e-cigarettes on smoking cessation compared with nicotine gum.
Methods: A total of 150 subjects were randomly assigned to 2 groups and each was allocated a 12-week supply of either e-cigarettes or nicotine gum. The continuous abstinence rate, 7-day point prevalence of abstinence, smoking reduction rate and amount, and tolerability were evaluated.
Results: There were no statistically significant differences in the effectiveness-related parameters of smoking cessation, such as 9- to 12-week, 9- to 24-week, and 12- and 24-week point prevalence of abstinence, between the 2 groups. However, although the reduction in cigarette smoking was similar, the proportion of subjects who showed smoking reduction at 24 weeks was higher in the e-cigarette group than the nicotine gum group. In addition, adverse events were significantly less frequent in the e-cigarette group than in the nicotine gum group.
Conclusions: In our study, the effect of e-cigarettes on smoking cessation was similar compared with that of nicotine gum, a well-documented NRT. In addition, e-cigarettes were well tolerated by the study population. Therefore, the use of e-cigarettes as an NRT may be considered for smoking-cessation purposes. A large-scale prospective randomized controlled trial is necessary to clarify our results.
Electronic cigarettes for smoking cessation.
Lindson N, Butler A, McRobbie H, Bullen C, Hajek P, Wu A Cochrane Database Syst Rev. 2025; 1:CD010216.
PMID: 39878158 PMC: 11776059. DOI: 10.1002/14651858.CD010216.pub9.
An overview of traditional smoking cessation interventions and E-cigarettes.
Alshehri F Front Pharmacol. 2024; 15:1293062.
PMID: 39104396 PMC: 11298375. DOI: 10.3389/fphar.2024.1293062.
Pluym N, Burkhardt T, Scherer G, Scherer M Harm Reduct J. 2024; 21(1):130.
PMID: 38970058 PMC: 11225172. DOI: 10.1186/s12954-024-01047-1.
Meng Y, Xiang S, Qu L, Li Y Front Public Health. 2024; 12:1361186.
PMID: 38841681 PMC: 11150810. DOI: 10.3389/fpubh.2024.1361186.
Campagna D, Farsalinos K, Costantino G, Carpinteri G, Caponnetto P, Cucuzza F JMIR Res Protoc. 2024; 13:e54041.
PMID: 38657239 PMC: 11079756. DOI: 10.2196/54041.